1. Home
  2. SHFS vs PPBT Comparison

SHFS vs PPBT Comparison

Compare SHFS & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHFS
  • PPBT
  • Stock Information
  • Founded
  • SHFS 2015
  • PPBT 2010
  • Country
  • SHFS United States
  • PPBT Israel
  • Employees
  • SHFS N/A
  • PPBT N/A
  • Industry
  • SHFS Finance: Consumer Services
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHFS Finance
  • PPBT Health Care
  • Exchange
  • SHFS Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • SHFS 6.3M
  • PPBT 6.2M
  • IPO Year
  • SHFS N/A
  • PPBT N/A
  • Fundamental
  • Price
  • SHFS $3.33
  • PPBT $1.36
  • Analyst Decision
  • SHFS
  • PPBT Strong Buy
  • Analyst Count
  • SHFS 0
  • PPBT 1
  • Target Price
  • SHFS N/A
  • PPBT $33.00
  • AVG Volume (30 Days)
  • SHFS 2.2M
  • PPBT 34.9K
  • Earning Date
  • SHFS 08-14-2025
  • PPBT 08-06-2025
  • Dividend Yield
  • SHFS N/A
  • PPBT N/A
  • EPS Growth
  • SHFS N/A
  • PPBT N/A
  • EPS
  • SHFS N/A
  • PPBT N/A
  • Revenue
  • SHFS $11,720,493.00
  • PPBT N/A
  • Revenue This Year
  • SHFS N/A
  • PPBT N/A
  • Revenue Next Year
  • SHFS N/A
  • PPBT N/A
  • P/E Ratio
  • SHFS N/A
  • PPBT N/A
  • Revenue Growth
  • SHFS N/A
  • PPBT N/A
  • 52 Week Low
  • SHFS $1.84
  • PPBT $1.40
  • 52 Week High
  • SHFS $13.00
  • PPBT $13.95
  • Technical
  • Relative Strength Index (RSI)
  • SHFS 64.59
  • PPBT 19.33
  • Support Level
  • SHFS $2.24
  • PPBT $2.17
  • Resistance Level
  • SHFS $4.29
  • PPBT $2.36
  • Average True Range (ATR)
  • SHFS 0.45
  • PPBT 0.19
  • MACD
  • SHFS 0.09
  • PPBT -0.08
  • Stochastic Oscillator
  • SHFS 68.93
  • PPBT 3.60

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: